The Ebola outbreak in the Democratic Republic of Congo has claimed 3,007 lives with 6,186 confirmed cases recorded, according to government data released on Wednesday, September 2, 2026. The epidemic, driven by the Bundibugyo species of the virus, was formally declared on May 15 in Ituri province, though health officials indicate transmissions may have begun in January.
Geographic Spread and Case Fatality Ratios
Official situation reports as of August 31, 2026, detail 6,186 confirmed cases, 3,007 deaths, 1,409 patient recoveries, and 830 individuals remaining in isolation or treatment centers. The epidemic spans six provinces, including Ituri, North Kivu, Haut-Uélé, Tshopo, South Kivu, and Bas-Uele, encompassing 60 health zones. Ituri accounts for the vast majority of infections at 81.9 percent of all confirmed cases.
Data from the World Health Organization places the crude case fatality ratio at 48.1 percent. The World Health Organization estimates that approximately 60 percent of all fatalities occur outside formal treatment centers. Over 40 health workers have died during the response efforts, while treatment facilities and ambulances have faced physical attacks.
International Response and Vaccine Deployment
Tom Fletcher, UN Under-Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator, warned during an online briefing, 'Unless we scale up urgently, more lives will be lost and the threat will grow.'
The World Health Organization stated, 'The crude case fatality ratio of 48 percent underscores the severity of the disease and ongoing challenges related to timely case detection, access to and quality of clinical care, and effective interruption of viral transmission.'
In response to the spread, the World Health Organization has recommended a phase three clinical trial for the Ervebo vaccine. While licensed primarily for the Zaire strain, the vaccine is believed to offer cross-protection against the Bundibugyo variant. Congolese authorities have initiated vaccinations for frontline health workers using this supply, as no approved vaccine or treatment currently exists specifically for the Bundibugyo strain.
Operational Challenges and Community Resistance
Health experts note that weak surveillance systems, ongoing regional insecurity, and deep community resistance have severely hindered early patient identification and treatment. Doctors Without Borders highlighted that 'Ebola disease is terrifying, and many people refrain from seeking healthcare out of fear to catch the virus in the health facilities or due to false rumours about the care that is provided there.'
This ongoing event represents the largest and deadliest epidemic in Congo's history, exceeding the scale of the 2018 to 2020 outbreak, and stands as the second-largest Ebola outbreak ever recorded globally, trailing only the 2014 to 2016 West African outbreak that infected over 28,600 people and caused more than 11,000 deaths across Guinea, Liberia, and Sierra Leone.
For the population across the six affected provinces, the ongoing crisis signifies continued high mortality rates and a severely strained healthcare infrastructure, compounded by conflict-driven displacement, food insecurity, and malnutrition that outpace current response capabilities.